Activation of mineralocorticoid receptors by exogenous glucocorticoids and the development of cardiovascular inflammatory responses in adrenalectomized rats

Endocrinology

Volumn 151, Issue 6, 2010, Pages 2622-2628

  Young, Morag J ^a   Morgan, James ^a   Brolin, Kim ^a   Fuller, Peter J ^a   Funder, John W ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBENOXOLONE; CONNECTIVE TISSUE GROWTH FACTOR; CORTICOSTERONE; DEOXYCORTICOSTERONE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN RECEPTOR; EPLERENONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; POTASSIUM CHLORIDE; PROTEIN P22; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SODIUM CHLORIDE; MINERALOCORTICOID; NOX4 PROTEIN, RAT; P22 PHOX PROTEIN, RAT; P22-PHOX PROTEIN, RAT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CELL INFILTRATION; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; HEART MUSCLE FIBROSIS; INFLAMMATORY CELL; KIDNEY; LIVER FIBROSIS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; HEART; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; METABOLISM; ORGAN SIZE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ADRENALECTOMY; ANIMALS; GLUCOCORTICOIDS; HEART; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY; MALE; MINERALOCORTICOIDS; NADPH OXIDASE; NITRIC OXIDE SYNTHASE TYPE III; ORGAN SIZE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77954503924     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-1476     Document Type: Article

References (34)

1. Berger S, Wolfer DP, Selbach O, Alter H, Erdmann G, Reichardt HM, Chepkova AN, Welzl H, Haas HL, Lipp HP, Schütz G 2006 Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity. Proc Natl Acad Sci USA 103:195-200
2. Caprio M, Fève B, Claës A, Viengchareun S, Lombès M, Zennaro MC 2007 Pivotal role of the mineralocorticoid receptor in corticosteroid- induced adipogenesis. FASEB J 21:2185-2194
3. Rickard AJ, Morgan J, Tesch G, Funder JW, Fuller PJ, Young MJ 2009 Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure. Hypertension 54:537-543
4. Armanini D, Strasser T, Weber PC 1985 Characterization of aldosterone binding sites in circulating human mononuclear leukocytes. Am J Physiol 248:E388-E390
5. Christy C, Hadoke PW, Paterson JM, Mullins JJ, Seckl JR, Walker BR2003 11β-hydroxysteroid dehydrogenase type 2 in mouse aorta: localization and influence on response to glucocorticoids. Hypertension 42:580-587
6. Pearce PT, Funder JW 1988 Steroid binding to cardiac type I receptors: in vivo studies. J Hypertens Suppl 6:S131-S133
7. Alzamora R, Michea L, Marusic ET 2000 Role of 11β-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries. Hypertension 35:1099-1104
8. Myles K, Funder JW 1996 Progesterone binding to mineralocorticoid receptors: in vitro and in vivo studies. Am J Physiol 270:E601-E607
9. Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT 2002 Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am J Pathol 161:1773-1781
10. Rocha R, Rudolph AE, Frierdich GE, Nachowiak DA, Kekec BK, Blomme EA, McMahon EG, Delyani JA 2002 Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol 283:H1802-H1810
11. Young M, Fullerton M, Dilley R, Funder J 1994 Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest 93:2578-2583
12. Young M, Head G, Funder J 1995 Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol 269:E657-E662
13. Wilson P, Morgan J, Funder JW, Fuller PJ, Young MJ 2009 Mediators of mineralocorticoid receptor-induced profibrotic inflammatory responses in the heart. Clin Sci (Lond) 116:731-739
14. Fujii A, Nakano D, Katsuragi M, Ohkita M, Takaoka M, Ohno Y, Matsumura Y 2006 Role of gp91phox-containing NADPH oxidase in the deoxycorticosterone acetate-salt-induced hypertension. Eur J Pharmacol 552:131-134
15. Sun Y, Carretero OA, Xu J, Rhaleb NE, Wang F, Lin C, Yang JJ, Pagano PJ, Yang XP 2005 Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate-salt hypertension. Hypertension 46:1355-1361
16. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Eng J Med 341:709-717
17. Pitt B, Williams G, Remme W, Martinez F, Lopez-Sendon J, Zannad F, Neaton J, Roniker B, Hurley S, Burns D, Bittman R, Kleiman J 2001 The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study. Cardiovasc Drugs Ther 15:79-87
18. Rickard AJ, Funder JW, Morgan J, Fuller PJ, Young MJ 2007 Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration? Endocrinology 148:4829-4835
19. Young MJ, Moussa L, Dilley R, Funder JW 2003 Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11β-hydroxysteroid dehydrogenase inactivation. Endocrinology 144:1121-1125
20. Rickard AJ, Funder JW, Fuller PJ, Young MJ 2006 The role of the glucocorticoid receptor in mineralocorticoid/salt mediated cardiac fibrosis. Endocrinology 147:5901-5906
21. Johar S, Cave AC, Narayanapanicker A, Grieve DJ, Shah AM 2006 Aldosteronemediatesangiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. FASEB J 20:1546-1548
22. Grieve DJ, Byrne JA, Siva A, Layland J, Johar S, Cave AC, Shah AM 2006 Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload. J Am Coll Cardiol 47:817-826
23. Byrne JA, Grieve DJ, Bendall JK, Li JM, Gove C, Lambeth JD, Cave AC, Shah AM 2003 Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ Res 93:802-805
24. Molnar GA, Lindschau C, Dubrovska G, Mertens PR, Kirsch T, Quinkler M, Gollasch M, Wresche S, Luft FC, Muller DN, Fiebeler A 2008 Glucocorticoid- related signaling effects in vascular smooth muscle cells. Hypertension 51:1372-1378
25. Wong S, Brennan FE, Young MJ, Fuller PJ, Cole TJ 2007 A direct effect of aldosterone on endothelin-1 gene expression in vivo. Endocrinology 148:1511-1517
26. Januszewicz A, Loń S, Lapiński M, Styś A 1994 Effect of endothelin-3 on blood pressure in conscious spontaneously hypertensive [SHR] and DOCA-salt hypertensive rats. J Physiol Pharmacol 45:105-119
27. Brennan FE, Fuller PJ 1999 Acute regulation by corticosteroids of channel-inducing factor gene messenger ribonucleic acid in the distal colon. Endocrinology 140:1213-1218
28. Tsugita M, Iwasaki Y, Nishiyama M, Taguchi T, Shinahara M, Taniguchi Y, Kambayashi M, Nishiyama A, Gomez-Sanchez CE, Terada Y, Hashimoto K 2009 Glucocorticoid receptor plays an indispensable role in mineralocorticoid receptor-dependent transcription in GR-deficient BE(2)C and T84 cells in vitro. Mol Cell Endocrinol 302:18-25
29. Trapp T, Rupprecht R, Castrén M, Reul JM, Holsboer F 1994 Heterodimerization between mineralocorticoid and glucocorticoid receptor: a new principle of glucocorticoid action in the CNS. Neuron 13:1457-1462
30. Savory JG, Préfontaine GG, Lamprecht C, Liao M, Walther RF, Lefebvre YA, Haché RJ 2001 Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces. Mol Cell Biol 21:781-793
31. Lam E, Morgan J, Funder J, Fuller P, Young M 2008 Novel early aldosterone/salt regulated genes in mineralocorticoid receptor-mediated cardiovascular response. Hypertension 52:170
32. Stavreva DA, Wiench M, John S, Conway-Campbell BL, McKenna MA, Pooley JR, Johnson TA, Voss TC, Lightman SL, Hager GL 2009 Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription. Nat Cell Biol 11:1093-1102
33. Desvergne B, Héligon C 2009 Steroid hormone pulsing drives cyclic gene expression. Nat Cell Biol 11:1051-1053
34. Crabbe J 1961 Stimulation of active sodium transport by the isolated toad bladder with aldosterone in vitro. J Clin Invest 40:2103-2110